Why I Use Both Prospective Randomized Trials and Registry Data When Choosing the Personalized Treatment of an AAA Patient

Gefasschirurgie - Germany
doi 10.1007/s00772-018-0434-4
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Commentary: On the Levels of Patient Selection in Registry-Based Randomized Controlled Trials

Trials
MedicinePharmacology
2019English

When Prospective Randomized Trials Have Unexpected Results: Where Do We Go From There?

BJOG: An International Journal of Obstetrics and Gynaecology
GynecologyObstetrics
2019English

224 Patient Preferences When Choosing a Dermatologist

Journal of Investigative Dermatology
BiochemistryDermatologyCell BiologyMolecular Biology
2019English

When Should ED Physicians Use an HIE? Predicting Presence of Patient Data in an HIE

Southern Medical Journal
Medicine
2016English

Correction To: The Use of Opioids in the Treatment of Osteoarthritis: When, Why, and How?

Current Rheumatology Reports
Rheumatology
2018English

Stepped-Wedge Cluster Randomised Trials: Where, When and Why?

Trials
MedicinePharmacology
2015English

Choosing an Imbalance Metric for Covariate-Constrained Randomization in Multiple-Arm Cluster-Randomized Trials

Trials
MedicinePharmacology
2019English

Choosing Versus Rejecting: Why Some Options Are Both Better and Worse Than Others

Memory and Cognition
ArtsNeuropsychologyCognitive PsychologyHumanitiesPhysiological PsychologyMedicineExperimental
1993English

Randomized Trials vs Data Banking

Circulation
Cardiovascular MedicinePhysiologyCardiology
1974English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy